MTOR inhibitor-based combination therapies for pancreatic cancer

机译：基于MTOR抑制剂的胰腺癌组合疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zonera Hassan; Christian Schneeweis; Matthias Wirth; Christian Veltkamp; Zahra Dantes; Benedikt Feuerecker; Güralp O Ceyhan; Shirley K Knauer; Wilko Weichert; Roland M Schmid; Roland Stauber; Alexander Arlt; Oliver H Krämer; Roland Rad; Maximilian Reichert; Dieter Saur; Günter Schneider;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study [J] . Joka Mareile, Boeck Stefan, Zech Christoph J., Anti-cancer drugs . 2014,第9期

机译：使用mTOR抑制剂依维莫司和低剂量化疗联合抗血管生成治疗局部晚期和/或转移性胰腺癌的剂量研究
2. Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study [J] . Joka Mareile, Boeck Stefan, Zech Christoph J., Anti-cancer drugs . 2014,第9期

机译：使用MTOR抑制剂extiolimus和低剂量化疗的抗血管生成治疗组合局部晚期和/或转移性胰腺癌：一种剂量发现研究
3. BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer [J] . Michael J Pishvaian, Andrew V Biankin, Peter Bailey, British Journal of Cancer . 2017,第8期

机译：胰腺癌中 BRCA2 二级突变介导的对铂和PARP抑制剂治疗的耐药性
4. Overcoming therapeutic resistance in pancreatic cancer is not a simple mix of PDT and chemotherapy: Evaluation of PDT-chemotherapy combinations in 3D tumor models [C] . Jonathan P. Celli, Ljubica Petrovic, Iqbal Massodi, Optical methods for tumor treatment and detection: mechanisms and techniques in photodynamic therapy XXII . 2013

机译：克服胰腺癌的治疗抗性不是PDT和化学疗法的简单组合：在3D肿瘤模型中评估PDT-化学疗法的组合
5. Survivin: Regulation by YY1 and Role in Pancreatic Cancer Combination Therapy. [D] . Galloway, Nicholas R. 2014

机译：Survivin：由YY1调控并在胰腺癌联合治疗中发挥作用。
6. MTOR inhibitor-based combination therapies for pancreatic cancer [O] . Zonera Hassan, Christian Schneeweis, Matthias Wirth, 2018

机译：基于MTOR抑制剂的胰腺癌联合疗法
7. BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer [O] . Pishvaian, Michael J., Biankin, Andrew V., Bailey, Peter, 2017

机译：BRCa2继发突变介导的对铂和paRp抑制剂治疗胰腺癌的耐药性

MTOR inhibitor-based combination therapies for pancreatic cancer

著录项

引文网络

相似文献

相关主题

期刊订阅